Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,652 public trials 850 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Latin American Real-world Study in Acute Leukemia

NCT05166135

Conditions
Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Burkitt Lymphoma, +22 more
Locations
  • Hospital Italiano de La Plata La Plata, Buenos Aires, Argentina
  • Hospital Universitario Austral Pilar, Buenos Aires, Argentina
  • FUNDALEU - Fundacion para combatir la Leucemia Buenos Aires, Ciudad Autonoma Buenos Aires, Argentina
  • Hospital Privado Centro Medico de Cordoba S.A. Córdoba, Argentina
View all 14 locations
View Trial Details
Completed

Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL)

NCT03792256

Conditions
Acute Leukemia, Disease Attributes, Hematologic Diseases, +22 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
View all 19 locations
View Trial Details
Completed

Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors

NCT05225584

Conditions
Cutaneous T-cell Lymphoma (CTCL), Hematologic Diseases, Hemic and Lymphatic Diseases, +22 more
Locations
  • UC Irvine Health-Chao Family Comprehensive Cancer Center Orange, California, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • Henry Ford Hospital Detroit, Michigan, United States
  • Hackensack University Medical Center, John Theurer Cancer Center Hackensack, New Jersey, United States
View all 13 locations
View Trial Details
Completed

A Non-interventional Study of REVLIMID® (Lenalidomide) Treatment of IPSS Low- or Intermediate-1-risk Myelodysplastic Syndromes Associated With a Deletion 5q or Refractory/Relapsed Mantle Cell Lymphoma in Korea

NCT04036448

Conditions
Bone Marrow Diseases, Disease Attributes, Hematologic Diseases, +15 more
Locations
  • Local Institution - S02 Seoul, Seoul Teugbyeolsi, South Korea
  • Hallym University Medical Center Anyang, South Korea
  • Keimyung University Dongsan Hospital Daegu, South Korea
  • Kyungpook National University Hospital Daegu, South Korea
View all 26 locations
View Trial Details
Completed

An Open-label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK3326595 in Participants With Solid Tumors and Non-Hodgkin's Lymphoma

NCT02783300

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +38 more
Locations
  • GSK Investigational Site Denver, Colorado, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site Nashville, Tennessee, United States
View all 15 locations
View Trial Details
Completed

Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease

NCT00719888

Conditions
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +65 more
Locations
  • University of Colorado Hospital Aurora, Colorado, United States
  • VA Puget Sound Health Care System Seattle, Washington, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details

Related conditions